YONEMORI Masaya 米森雅也

Researcher Number	00758013
Affiliation (based on the past Project Information) *help	2020: 鹿児島大学, 医歯学総合研究科, 客員研究員 2019: 鹿児島大学, 鹿児島大学病院, 医員 2017 – 2018: 鹿児島大学, 附属病院, 医員
Review Section/Research Field	Principal Investigator Basic Section 56030:Urology-related / Urology Except Principal Investigator Urology
Keywords	Principal Investigator CRISPRライブラリー / 進行性膀胱癌 / シスプラチン耐性 / GC療法抵抗性 / 膀胱癌 / microRNA / HIF / 腎細胞癌 / PHGDG / 低酸素誘導因子 / PHGDH / CRISPR/Cas9 / 腎癌 … More Except Principal Investigator … More ゲノム / microRNA / 進行性膀胱癌 / 膀胱癌 / マイクロRNA Less

Development of the marker predicting GC primary resistance of the bladder cancer by multifaceted approachPrincipal Investigator
- Principal Investigator
  
  YONEMORI Masaya
- Project Period (FY)
  2019 – 2020
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 56030:Urology-related
- Research Institution
  Kagoshima University
Elucidation of the resistance mechanism to the molecular targeting drug in renal cancer using the genome editing technologyPrincipal Investigator
- Principal Investigator
  
  YONEMORI Masaya
- Project Period (FY)
  2017 – 2018
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kagoshima University
Investigation of the molecular network regulated by novel tumor suppressive microRNAs in bladder cancer
- Principal Investigator
  
  MATSUSHITA Ryosuke
- Project Period (FY)
  2016 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Urology
- Research Institution
  Kagoshima University

All 2021 2020 2019 2018 2017 2016 Other

All Journal Article Presentation Other

[Journal Article] EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer2021
- Author(s)
  Okamura Shunsuke、Yoshino Hirofumi、Kuroshima Kazuki、Tsuruda Masafumi、Osako Yoichi、Sakaguchi Takashi、Yonemori Masaya、Yamada Yasutoshi、Tatarano Shuichi、Nakagawa Masayuki、Enokida Hideki
- Journal Title
  
  BMC Cancer
  
  Volume: 21 Issue: 1 Pages: 48-48
- DOI
  10.1186/s12885-020-07717-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-20K18146, KAKENHI-PROJECT-18K09198, KAKENHI-PROJECT-19K18615
[Journal Article] Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation2020
- Author(s)
  Hirofumi Yoshino, Hideki Enokida, Yoichi Osako, Nijiro Nohata, Masaya Yonemori, Satoshi Sugita, Kazuki Kuroshima, Masafumi Tsuruda, Shuichi Tatarano, Masayuki Nakagawa.
- Journal Title
  
  Molecular Oncology
  
  Volume: 54 Issue: 9 Pages: 2190-2202
- DOI
  10.1002/1878-0261.12697
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K09715, KAKENHI-PROJECT-20K18146, KAKENHI-PROJECT-18K09198, KAKENHI-PROJECT-19K18615
[Journal Article] Potential tumor-suppressive role of microRNA-99-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM22019
- Author(s)
  Osako Y, Yoshino H, Sakaguchi T, Sugita S, Yonemori M, Nakagawa M, Enokida H.
- Journal Title
  
  International Journal of Oncology
  
  Volume: 54 Pages: 1759-1770
- DOI
  10.3892/ijo.2019.4736
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-16H05464, KAKENHI-PROJECT-17K16799, KAKENHI-PROJECT-19K07736, KAKENHI-PROJECT-19K18615, KAKENHI-PROJECT-17K11148
[Journal Article] HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.2019
- Author(s)
  Sugita S, Enokida H, Yoshino H, Miyamoto K, Yonemori M, Sakaguchi T, Osako Y, Nakagawa M.
- Journal Title
  
  Int J Oncol.
  
  Volume: 53 Pages: 725-736
- DOI
  10.3892/ijo.2018.4435
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-17H04332, KAKENHI-PROJECT-17K16799
[Journal Article] Tumor suppressive microRNA223 targets WDR62 directly in bladder cancer.2019
- Author(s)
  Sugita S, Yoshino H, Yonemori M, Miyamoto K, Matsushita R, Sakaguchi T, Itesako T, Tatarano S, Nakagawa M, Enokida H.
- Journal Title
  
  Int J Oncol.
  
  Volume: 54 Pages: 2222-2236
- DOI
  10.3892/ijo.2019.4762
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04332, KAKENHI-PROJECT-17K16799, KAKENHI-PROJECT-19K07736, KAKENHI-PROJECT-19K09715, KAKENHI-PROJECT-19K18615
[Journal Article] Downregulation of microRNA-1274a induces cell apoptosis through regulation of2018
- Author(s)
  Yoshino H, Yonezawa T, Yonemori M, Miyamoto K, Sakaguchi T, Sugita S, Osako Y, Tatarano S, Nakagawa M, Enokida H.
- Journal Title
  
  Oncol Rep
  
  Volume: 39 Pages: 173-181
- DOI
  10.3892/or.2017.6098
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K11015, KAKENHI-PROJECT-16K15691, KAKENHI-PROJECT-17K16799, KAKENHI-PROJECT-16H05464
[Journal Article] Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.2018
- Author(s)
  Sakaguchi T, Yoshino H, Sugita S, Miyamoto K, Yonemori M, Osako Y, Meguro-Horike M, Horike SI, Nakagawa M, Enokida H.
- Journal Title
  
  Oncotarget
  
  Volume: 9 Issue: 33 Pages: 23003-23017
- DOI
  10.18632/oncotarget.25190
- Open Access
- Data Source
  KAKENHI-PROJECT-17K16799
[Journal Article] PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.2017
- Author(s)
  Yoshino H, Nohata N, Miyamoto K, Yonemori M, Sakaguchi T, Sugita S, Itesako T, Kofuji S, Nakagawa M, Dahiya R, Enokida H.
- Journal Title
  
  Cancer Res
  
  Volume: 77 Pages: 6321-6329
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16799
[Journal Article] microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.2017
- Author(s)
  Yoshino H, Yonemori M, Miyamoto K, Tatarano S, Kofuji S, Nohata N, Nakagawa M, Enokida H.
- Journal Title
  
  Oncotarget
  
  Volume: 8 Issue: 13 Pages: 20881-20894
- DOI
  10.18632/oncotarget.14930
- Peer Reviewed / Acknowledgement Compliant / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16H05464, KAKENHI-PROJECT-16K11015, KAKENHI-PROJECT-17K16799
[Journal Article] Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.2017
- Author(s)
  Sakaguchi T, Yoshino H, Yonemori M, Miyamoto K, Sugita S, Matsushita R, Itesako T, Tatarano S, Nakagawa M, Enokida H.
- Journal Title
  
  British Journal of Cancer
  
  Volume: 116 Issue: 8 Pages: 1077-1087
- DOI
  10.1038/bjc.2017.43
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-26293354, KAKENHI-PROJECT-16K11015, KAKENHI-PROJECT-16K15691, KAKENHI-PROJECT-17H04332, KAKENHI-PROJECT-16K20145
[Journal Article] Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer2016
- Author(s)
  Miyamoto K, Seki N, Matsushita R, Yonemori M, Yoshino H, Nakagawa M, Enokida H.
- Journal Title
  
  British Journal of Cancer
  
  Volume: 115 Issue: 3 Pages: 354-363
- DOI
  10.1038/bjc.2016.179
- Peer Reviewed / Acknowledgement Compliant
- Data Source
  KAKENHI-PROJECT-26293354, KAKENHI-PROJECT-26462416, KAKENHI-PROJECT-16K11015, KAKENHI-PROJECT-16K20145
[Journal Article] Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.2016
- Author(s)
  Yonemori M, Seki N, Yoshino H, Matsushita R, Miyamoto K, Nakagawa M, Enokida H.
- Journal Title
  
  Cancer Science
  
  Volume: 107 Issue: 9 Pages: 1233-1242
- DOI
  10.1111/cas.13002
- Peer Reviewed / Acknowledgement Compliant / Open Access
- Data Source
  KAKENHI-PROJECT-26293354, KAKENHI-PROJECT-16K11015, KAKENHI-PROJECT-16K20145
[Presentation] 代謝リプログラミングを標的とした腎癌治療薬抵抗性獲得機序の解明と克服2018
- Author(s)
  吉野裕史、宮元一隆、米森雅也、杉田　智、坂口　大、榎田英樹、中川昌之
- Organizer
  日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-17K16799
[Presentation] ゲノム編集技術（CRISPR/Cas9）を使用した腎癌における分子標的治療薬への耐性化機序の解明と革新的治療法の開発2018
- Author(s)
  米森雅也，吉野裕史，宮元一隆，坂口大，杉田智，榎田英樹，中川昌之．
- Organizer
  第106回日本泌尿器科学会総会
- Data Source
  KAKENHI-PROJECT-17K16799
[Presentation] Tumor-suppressive microRNA-26a-5p/-26b-5p inhibit cancer cell migration and invasion through targeting PLOD2 that is a potential prognostic marker in bladder cancer.2017
- Author(s)
  Miyamoto K, Seki N, Matsushita R, Yonemori M, Yoshino H, Sakaguchi T, Sugita S, Enokida H, Nakagawa M.
- Organizer
  American Urological Association (AUA) annual meeting
- Place of Presentation
  Boston (USA)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20145
[Presentation] Tumor-suppressive microRNA-26a-5p/-26b-5p inhibit cancer cell migration and invasion through targeting PLOD2 that is a potential prognostic marker in bladder cancer2017
- Author(s)
  Kazutaka Miyamoto, Kagoshima, Japan, Naohiko Seki, Ryosuke Matsushita, Masaya Yonemori, Hirofumi Yoshino, Takashi Sakaguchi, Satoshi Sugita, Hideki Enokida, Masayuki Nakagawa
- Organizer
  米国泌尿器科学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20145
[Presentation] Elucidation of the resistance mechanism to the molecular target drugs in renal cell carcinoma using the genome editing technology2017
- Author(s)
  Hideki Enokida, Hirofumi Yoshino, Kazutaka Miyamoto, Masaya Yonemori, Masayuki Nakagawa
- Organizer
  米国泌尿器科学会
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-17K16799
[Presentation] Dual tumor-suppressors (miR-145-5p/miR-145-3p) inducing cancer cell apoptosis via direct targeting UHRF1 in bladder cancer2016
- Author(s)
  Matsushita R, Seki N, Yoshino H, Miyamoto K, Yonemori M, Kurozumi A, Goto Y, Enokida H, Nakagawa M.
- Organizer
  American Urological Association (AUA) annual meeting
- Place of Presentation
  San Diego (USA)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20145
[Presentation] Dual tumor-suppressors miR-139-5p/-3p derived from pre-miR-139 via targeting matrix metalloprotease 11 (MMP11) in bladder cancer2016
- Author(s)
  Yonemori M, Seki N, Matsushita R, Miyamoto K, Yoshino H, Goto Y, Kato M, Kurozumi A, Nakagawa M, Enokida H
- Organizer
  American Urological Association (AUA) annual meeting
- Place of Presentation
  San Diego (USA)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K20145
[]

1. ENOKIDA Hideki (80347103)

# of Collaborated Projects: 2 results

# of Collaborated Products: 18 results
2. YOSHINO Hirofumi (90642611)

# of Collaborated Projects: 2 results

# of Collaborated Products: 15 results
3. MATSUSHITA Ryosuke (80735366)

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
4. Nakagawa Masayuki

# of Collaborated Projects: 1 results

# of Collaborated Products: 13 results
5. Nohata Nijiro

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. Sugita Satoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
7. Sakaguchi Satoshi

# of Collaborated Projects: 1 results

# of Collaborated Products: 4 results
8. MIYAMOTO Kazutaka

# of Collaborated Projects: 1 results

# of Collaborated Products: 6 results
9. Gutkind JS

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 関直彦

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
11. 大迫洋一

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results

YONEMORI Masaya 米森 雅也

Research Projects

Research Products

Co-Researchers

Development of the marker predicting GC primary resistance of the bladder cancer by multifaceted approachPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Elucidation of the resistance mechanism to the molecular targeting drug in renal cancer using the genome editing technologyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Investigation of the molecular network regulated by novel tumor suppressive microRNAs in bladder cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] EHHADH contributes to cisplatin resistance through regulation by tumor-suppressive microRNAs in bladder cancer2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Characterization of PHGDH expression in bladder cancer: potential targeting therapy with gemcitabine/cisplatin and the contribution of promoter DNA hypomethylation2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Potential tumor-suppressive role of microRNA-99-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM22019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] HRAS as a potential therapeutic target of salirasib RAS inhibitor in bladder cancer.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumor suppressive microRNA223 targets WDR62 directly in bladder cancer.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Downregulation of microRNA-1274a induces cell apoptosis through regulation of2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Bromodomain protein BRD4 inhibitor JQ1 regulates potential prognostic molecules in advanced renal cell carcinoma.2018

Author(s)

Journal Title

DOI

Data Source

[Journal Article] PHGDH as a Key Enzyme for Serine Biosynthesis in HIF2α-Targeting Therapy for Renal Cell Carcinoma.2017

Author(s)

Journal Title

Data Source

[Journal Article] microRNA-210-3p depletion by CRISPR/Cas9 promoted tumorigenesis through revival of TWIST1 in renal cell carcinoma.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Regulation of ITGA3 by the dual-stranded microRNA-199 family as a potential prognostic marker in bladder cancer.2017

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Tumour-suppressive miRNA-26a-5p and miR-26b-5p inhibit cell aggressiveness by regulating PLOD2 in bladder cancer2016

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Dual tumor-suppressors miR-139-5p and miR-139-3p targeting matrix metalloprotease 11 in bladder cancer.2016

Author(s)

Journal Title

DOI

YONEMORI Masaya 米森雅也